WISE is a biomedical company developing a new generation of implantable leads for Neuromodulation and Neuromonitoring.

WISE’s electrodes are highly biocompatible, foldable, stretchable, and minimally invasive and will overcome many limitations of today’s technology. They will allow to improve the treatment of patients that are already profiting from Neuromodulation, while at the same time expanding the use of Neuromodulation to fields and clinical indications in which the complex technical demands cannot be met by the current technology. Wise achieved the CE marking on its first product in 2021.

Atlante Seed initially invested in the company in 2013. The following rounds were financed by several Italian and international investors, including Atlante Ventures and Indaco Ventures I as well.